pentetic acid has been researched along with Glycogen Storage Disease Type I in 1 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, L | 1 |
| Dahlem, S | 1 |
| Goldfarb, S | 1 |
| Kern, EF | 1 |
| Stanley, CA | 1 |
| Egler, J | 1 |
| Olshan, JS | 1 |
| Heyman, S | 1 |
1 other study available for pentetic acid and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Hyperfiltration and renal disease in glycogen storage disease, type I.
Topics: Adolescent; Adult; Albuminuria; Child; Child, Preschool; Creatinine; Female; Glomerular Filtration R | 1989 |